Autophagy–Lysosomal Systems in Parkinson’s Disease

by | Jan 13, 2025

Juozas Gordevicius, PhD, Chief Technology Officer of VUGENE Vilnius, Lithuania, discusses  autophagy-lysosomal systems in Parkinson’s disease.     Parkinson’s disease is a neurological disorder causing unintended or uncontrollable movements, such as shaking,...

Hypoparathyroidism

by | Jan 12, 2025

Hypoparathyroidism is a rare endocrine disorder characterized by a deficiency of parathyroid hormone (PTH), which leads to decreased serum calcium and increased phosphorus levels in the blood.   Etiology The most common cause of hypoparathyroidism is unintended...

Epigenetics and Epigenomics in Lysosomal Disorders

by | Jan 10, 2025

Gregory Grabowski, MD, discusses the use of whole genome sequencing and artificial intelligence (AI) in epigenetics and epigenomics.     Epigenetics and epigenomics provide critical insights into why family members with the same disease may exhibit distinct...

Artificial Intelligence in Healthcare

by | Jan 9, 2025

David Smerkous, AI PhD Student, Oregon State University, discusses artificial intelligence (AI) in healthcare.     Mr. Smerkous describes concerns relating to AI, including its impact on the jobs of laboratory technicians. While this technology can help with...

Recent Advances in Fabry Disease Clinical Research

by | Jan 8, 2025

David Warnock, MD, Professor of Medicine (Emeritus), University of Alabama at Birmingham, discusses recent advances in Fabry disease clinical research.     Fabry disease is a rare genetic, multisystemic lysosomal disease characterized by specific cutaneous,...